Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 1
1985 1
1986 1
1987 1
1988 1
1989 2
1990 2
1991 2
1992 3
1993 1
1995 2
1997 2
1998 1
1999 3
2000 4
2001 1
2002 1
2003 1
2004 4
2005 1
2006 5
2007 6
2008 8
2009 12
2010 7
2011 6
2012 4
2013 7
2014 4
2015 6
2016 6
2017 4
2018 4
2019 6
2020 2
2021 6
2022 1
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.
Hochberg MC, Guermazi A, Guehring H, Aydemir A, Wax S, Fleuranceau-Morel P, Reinstrup Bihlet A, Byrjalsen I, Ragnar Andersen J, Eckstein F. Hochberg MC, et al. Among authors: byrjalsen i. JAMA. 2019 Oct 8;322(14):1360-1370. doi: 10.1001/jama.2019.14735. JAMA. 2019. PMID: 31593273 Free PMC article. Clinical Trial.
Is bone quality associated with collagen age?
Leeming DJ, Henriksen K, Byrjalsen I, Qvist P, Madsen SH, Garnero P, Karsdal MA. Leeming DJ, et al. Among authors: byrjalsen i. Osteoporos Int. 2009 Sep;20(9):1461-70. doi: 10.1007/s00198-009-0904-3. Epub 2009 Mar 28. Osteoporos Int. 2009. PMID: 19330423 Review.
Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study.
Eckstein F, Hochberg MC, Guehring H, Moreau F, Ona V, Bihlet AR, Byrjalsen I, Andersen JR, Daelken B, Guenther O, Ladel C, Michaelis M, Conaghan PG. Eckstein F, et al. Among authors: byrjalsen i. Ann Rheum Dis. 2021 Aug;80(8):1062-1069. doi: 10.1136/annrheumdis-2020-219181. Epub 2021 May 7. Ann Rheum Dis. 2021. PMID: 33962962 Free PMC article. Clinical Trial.
Impact of monitoring approaches on data quality in clinical trials.
Andersen JR, von Sehested C, Byrjalsen I, Popik S, Follin AB, Bihlet AR. Andersen JR, et al. Among authors: byrjalsen i. Br J Clin Pharmacol. 2023 Jun;89(6):1756-1766. doi: 10.1111/bcp.15615. Epub 2023 Jan 3. Br J Clin Pharmacol. 2023. PMID: 36478289 Free article.
Cohort Profile: The Prospective Epidemiological Risk Factor (PERF) study.
Neergaard JS, Dragsbæk K, Kehlet SN, Hansen HB, Hansen G, Byrjalsen I, Alexandersen P, Lindgren LM, Bihlet AR, Riis BJ, Andersen JR, Qvist P, Karsdal MA, Christiansen C. Neergaard JS, et al. Among authors: byrjalsen i. Int J Epidemiol. 2017 Aug 1;46(4):1104-1104i. doi: 10.1093/ije/dyw251. Int J Epidemiol. 2017. PMID: 27789666 No abstract available.
Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development.
Karsdal MA, Henriksen K, Leeming DJ, Mitchell P, Duffin K, Barascuk N, Klickstein L, Aggarwal P, Nemirovskiy O, Byrjalsen I, Qvist P, Bay-Jensen AC, Dam EB, Madsen SH, Christiansen C. Karsdal MA, et al. Among authors: byrjalsen i. Biomarkers. 2009 May;14(3):181-202. doi: 10.1080/13547500902777608. Biomarkers. 2009. PMID: 19399662 Review.
119 results